Cardiac regeneration using pluripotent stem cells-Progression to large animal models

Stem Cell Research

Volumn 13, Issue 3, 2014, Pages 654-665

  Chong, James J H ^a,b,c,d   Murry, Charles E ^d,e  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF WASHINGTON   (United States)

^e University of Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; APOPTOSIS; ARRHYTHMOGENESIS; BONE MARROW DERIVED MONONUCLEAR CELL; CARDIAC REGENERATION; CARDIAC STEM CELL; CELL DEATH; CELL POPULATION; CELL SELECTION; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; CELL TRANSPLANTATION; ELECTROCARDIOGRAM; EMBRYONIC STEM CELL; ENGRAFTMENT; EXCITATION CONTRACTION COUPLING; HEART WEIGHT; HUMAN; MYOBLAST; NONHUMAN; REVIEW; TISSUE REGENERATION; UPREGULATION; ANIMAL; BIOLOGICAL THERAPY; CYTOLOGY; DISEASE MODEL; HEART; HEART MUSCLE CELL; ISCHEMIA; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; REGENERATION; TRANSPLANTATION;

ANIMALIA;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; HEART; HUMANS; ISCHEMIA; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; REGENERATION;

EID: 84911406536     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.06.005     Document Type: Review

References (82)

1. Askoxylakis V., Thieke C., Pleger S.T., Most P., Tanner J., Lindel K., Bischof M. Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer 2010, 10:105. 10.1186/1471-2407-10-105.
2. Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., Zeiher A.M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002, 106(24):3009-3017.
3. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428(6983):668-673.
4. Bel A., Planat-Bernard V., Saito A., Bonnevie L., Bellamy V., Sabbah L., Menasche P. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 2010, 122(11 Suppl.):S118-S123. 10.1161/CIRCULATIONAHA.109.927293.
5. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114(6):763-776.
6. Blin G., Nury D., Stefanovic S., Neri T., Guillevic O., Brinon B., Puceat M. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 2010, 120(4):1125-1139. (40120 [pii]). 10.1172/JCI40120.
7. Bolli R., Chugh A.R., D'Amario D., Loughran J.H., Stoddard M.F., Ikram S., Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011, 378(9806):1847-1857. (S0140-6736(11)61590-0 [pii]). 10.1016/S0140-6736(11)61590-0.
8. Bolli R., Tang X.L., Sanganalmath S.K., Rimoldi O., Mosna F., Abdel-Latif A., Kajstura J. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 2013, 128(2):122-131. 10.1161/CIRCULATIONAHA.112.001075.
9. Burridge P.W., Keller G., Gold J.D., Wu J.C. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012, 10(1):16-28. 10.1016/j.stem.2011.12.013.
10. Caspi O., Huber I., Kehat I., Habib M., Arbel G., Gepstein A., Gepstein L. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 2007, 50(19):1884-1893. (S0735-1097(07)02635-6 [pii]). 10.1016/j.jacc.2007.07.054.
11. Chong J.J., Yang X., Don C.W., Minami E., Liu Y.W., Weyers J.J., Murry C.E. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014, 10.1038/nature13233.
12. Dixon J.A., Gorman R.C., Stroud R.E., Bouges S., Hirotsugu H., Gorman J.H., Spinale F.G. Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation 2009, 120(11 Suppl.):S220-S229. 10.1161/CIRCULATIONAHA.108.842302.
13. Dixon J.A., Spinale F.G. Large animal models of heart failure: a critical link in the translation of basic science to clinical practice. Circ. Heart Fail 2009, 2(3):262-271. 10.1161/CIRCHEARTFAILURE.108.814459.
14. 2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 2006, 24(2):236-245. 10.1634/stemcells.2005-0036.
15. Dubois N.C., Craft A.M., Sharma P., Elliott D.A., Stanley E.G., Elefanty A.G., Keller G. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat. Biotechnol. 2011, 29(11):1011-1018. 10.1038/nbt.2005.
16. Ellison G.M., Torella D., Dellegrottaglie S., Perez-Martinez C., Perez de Prado A., Vicinanza C., Nadal-Ginard B. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J. Am. Coll. Cardiol. 2011, 58(9):977-986. 10.1016/j.jacc.2011.05.013.
17. Fernandes S., Naumova A.V., Zhu W.Z., Laflamme M.A., Gold J., Murry C.E. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J. Mol. Cell. Cardiol. 2010, 49(6):941-949. (S0022-2828(10)00339-1 [pii]). 10.1016/j.yjmcc.2010.09.008.
18. Gandolfi F., Vanelli A., Pennarossa G., Rahaman M., Acocella F., Brevini T.A. Large animal models for cardiac stem cell therapies. Theriogenology 2011, 75(8):1416-1425. (S0093-691X(11)00063-X [pii]). 10.1016/j.theriogenology.2011.01.026.
19. Gepstein L., Ding C., Rahmutula D., Wilson E.E., Yankelson L., Caspi O., Olgin J.E. In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells 2010, 28(12):2151-2161. 10.1002/stem.545.
20. Ginis I., Luo Y., Miura T., Thies S., Brandenberger R., Gerecht-Nir S., Rao M.S. Differences between human and mouse embryonic stem cells. Dev. Biol. 2004, 269(2):360-380. 10.1016/j.ydbio.2003.12.034.
21. Grieve S.M., Bhindi R., Seow J., Doyle A., Turner A.J., Tomka J., Figtree G.A. Microvascular obstruction by intracoronary delivery of mesenchymal stem cells and quantification of resulting myocardial infarction by cardiac magnetic resonance. Circ. Heart Fail 2010, 3(3):e5-e6. 10.1161/CIRCHEARTFAILURE.109.931360.
22. Haghighi K., Kolokathis F., Pater L., Lynch R.A., Asahi M., Gramolini A.O., Kranias E.G. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J. Clin. Invest. 2003, 111(6):869-876. 10.1172/JCI17892.
23. Hare J.M., Traverse J.H., Henry T.D., Dib N., Strumpf R.K., Schulman S.P., Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 2009, 54(24):2277-2286.
24. Hatzistergos K.E., Quevedo H., Oskouei B.N., Hu Q., Feigenbaum G.S., Margitich I.S., Hare J.M. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ. Res. 2010, 107(7):913-922. 10.1161/CIRCRESAHA.110.222703.
25. Heldman A.W., Difede D.L., Fishman J.E., Zambrano J.P., Trachtenberg B.H., Karantalis V., Hare J.M. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 2013, 10.1001/jama.2013.282909.
26. Hendrikx M., Hensen K., Clijsters C., Jongen H., Koninckx R., Bijnens E., Rummens J.L. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006, 114(1 Suppl.):I101-I107. 10.1161/CIRCULATIONAHA.105.000505.
27. Hoshino T., Fujiwara H., Kawai C., Hamashima Y. Myocardial fiber diameter and regional distribution in the ventricular wall of normal adult hearts, hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation 1983, 67(5):1109-1116.
28. Hou X., Appleby N., Fuentes T., Longo L.D., Bailey L.L., Hasaniya N., Kearns-Jonker M. Isolation, characterization, and spatial distribution of cardiac progenitor cells in the sheep heart. J. Clin. Exp. Cardiol. 2012, S6.
29. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., Van de Werf F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006, 367(9505):113-121. 10.1016/S0140-6736(05)67861-0.
30. Johnston P.V., Sasano T., Mills K., Evers R., Lee S.T., Smith R.R., Marban E. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 2009, 120(12):1075-1083. (1077 pp. following 1083. doi: CIRCULATIONAHA.108.816058 [pii]). 10.1161/CIRCULATIONAHA.108.816058.
31. Kawamura M., Miyagawa S., Miki K., Saito A., Fukushima S., Higuchi T., Sawa Y. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 2012, 126(11 Suppl. 1):S29-S37. 10.1161/CIRCULATIONAHA.111.084343.
32. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 2001, 108(3):407-414. 10.1172/JCI12131.
33. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., Gepstein L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 2004, 22(10):1282-1289. 10.1038/nbt1014.
34. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Murry C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25(9):1015-1024. (nbt1327 [pii]). 10.1038/nbt1327.
35. Laflamme M.A., Gold J., Xu C., Hassanipour M., Rosler E., Police S., Murry C.E. Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 2005, 167(3):663-671. (S0002-9440(10)62041-X [pii]). 10.1016/S0002-9440(10)62041-X.
36. Li T.S., Cheng K., Malliaras K., Smith R.R., Zhang Y., Sun B., Marban E. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J. Am. Coll. Cardiol. 2012, 59(10):942-953. 10.1016/j.jacc.2011.11.029.
37. Lian X., Hsiao C., Wilson G., Zhu K., Hazeltine L.B., Azarin S.M., Palecek S.P. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(27):E1848-E1857. 10.1073/pnas.1200250109.
38. Lieu D.K., Fu J.D., Chiamvimonvat N., Tung K.C., McNerney G.P., Huser T., Li R.A. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Arrhythm Electrophysiol. 2013, 6(1):191-201. 10.1161/CIRCEP.111.973420.
39. Linke A., Muller P., Nurzynska D., Casarsa C., Torella D., Nascimbene A., Anversa P. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(25):8966-8971. (0502678102 [pii]). 10.1073/pnas.0502678102.
40. Liu J., Fu J.D., Siu C.W., Li R.A. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 2007, 25(12):3038-3044. 10.1634/stemcells.2007-0549.
41. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., Murray C.J. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2095-2128. (S0140-6736(12)61728-0 [pii]). 10.1016/S0140-6736(12)61728-0.
42. Makkar R.R., Smith R.R., Cheng K., Malliaras K., Thomson L.E., Berman D., Marban E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012, 379(9819):895-904. (S0140-6736(12)60195-0 [pii]). 10.1016/S0140-6736(12)60195-0.
43. Malliaras K., Li T.S., Luthringer D., Terrovitis J., Cheng K., Chakravarty T., Marban E. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 2012, 125(1):100-112. 10.1161/CIRCULATIONAHA.111.042598.
44. Menard C., Hagege A.A., Agbulut O., Barro M., Morichetti M.C., Brasselet C., Menasche P. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 2005, 366(9490):1005-1012. 10.1016/S0140-6736(05)67380-1.
45. Menasche P., Alfieri O., Janssens S., McKenna W., Reichenspurner H., Trinquart L., Hagege A.A. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117(9):1189-1200. (CIRCULATIONAHA.107.734103 [pii]). 10.1161/CIRCULATIONAHA.107.734103.
46. Menasche P., Hagege A.A., Vilquin J.T., Desnos M., Abergel E., Pouzet B., Duboc D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 2003, 41(7):1078-1083. (doi: S0735109703000925 [pii]).
47. Mirotsou M., Jayawardena T.M., Schmeckpeper J., Gnecchi M., Dzau V.J. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J. Mol. Cell. Cardiol. 2011, 50(2):280-289. 10.1016/j.yjmcc.2010.08.005.
48. Mirotsou M., Zhang Z., Deb A., Zhang L., Gnecchi M., Noiseux N., Dzau V. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(5):1643-1648. 10.1073/pnas.0610024104.
49. Mocini D., Staibano M., Mele L., Giannantoni P., Menichella G., Colivicchi F., Santini M. Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting. Am. Heart J. 2006, 151(1):192-197. 10.1016/j.ahj.2005.02.001.
50. Mummery C.L., Zhang J., Ng E.S., Elliott D.A., Elefanty A.G., Kamp T.J. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 2012, 111(3):344-358. 10.1161/CIRCRESAHA.110.227512.
51. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132(4):661-680. (S0092-8674(08)00216-X [pii]). 10.1016/j.cell.2008.02.008.
52. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Field L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428(6983):664-668.
53. Murry C.E., Wiseman R.W., Schwartz S.M., Hauschka S.D. Skeletal myoblast transplantation for repair of myocardial necrosis. J. Clin. Invest. 1996, 98(11):2512-2523. 10.1172/JCI119070.
54. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410(6829):701-705.
55. Ota T., Patronik N.A., Schwartzman D., Riviere C.N., Zenati M.A. Minimally invasive epicardial injections using a novel semiautonomous robotic device. Circulation 2008, 118(14 Suppl.):S115-S120. 10.1161/CIRCULATIONAHA.107.756049.
56. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Mesquita C.T., Willerson J.T. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003, 107(18):2294-2302. 10.1161/01.CIR.0000070596.30552.8B.
57. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Silva G.V., Willerson J.T. Improved exercise capacity and ischemia 6 and 12months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2004, 110(11 Suppl. 1):II213-II218. 10.1161/01.CIR.0000138398.77550.62.
58. Perin E.C., Silva G.V., Assad J.A., Vela D., Buja L.M., Sousa A.L., Willerson J.T. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J. Mol. Cell. Cardiol. 2008, 44(3):486-495. 10.1016/j.yjmcc.2007.09.012.
59. Rakusan K., Nagai J. Morphometry of arterioles and capillaries in hearts of senescent mice. Cardiovasc. Res. 1994, 28(7):969-972.
60. Reinecke H., MacDonald G.H., Hauschka S.D., Murry C.E. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J. Cell Biol. 2000, 149(3):731-740.
61. Reinecke H., Poppa V., Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell. Cardiol. 2002, 34(2):241-249. 10.1006/jmcc.2001.1507.
62. Robey T.E., Saiget M.K., Reinecke H., Murry C.E. Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell. Cardiol. 2008, 45(4):567-581. (S0022-2828(08)00353-2 [pii]). 10.1016/j.yjmcc.2008.03.009.
63. Roell W., Lewalter T., Sasse P., Tallini Y.N., Choi B.R., Breitbach M., Fleischmann B.K. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007, 450(7171):819-824. 10.1038/nature06321.
64. Shake J.G., Gruber P.J., Baumgartner W.A., Senechal G., Meyers J., Redmond J.M., Martin B.J. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 2002, 73(6):1919-1925. (discussion 1926).
65. Shiba Y., Fernandes S., Zhu W.Z., Filice D., Muskheli V., Kim J., Laflamme M.A. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012, 489(7415):322-325. (nature11317 [pii]). 10.1038/nature11317.
66. Shintani Y., Fukushima S., Varela-Carver A., Lee J., Coppen S.R., Takahashi K., Suzuki K. Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure. J. Mol. Cell. Cardiol. 2009, 47(2):288-295. 10.1016/j.yjmcc.2009.05.009.
67. Siminiak T., Kalawski R., Fiszer D., Jerzykowska O., Rzezniczak J., Rozwadowska N., Kurpisz M. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12months of follow-up. Am. Heart J. 2004, 148(3):531-537. 10.1016/j.ahj.2004.03.043.
68. Smith R.R., Barile L., Cho H.C., Leppo M.K., Hare J.M., Messina E., Marban E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115(7):896-908.
69. Smits P.C., van Geuns R.J., Poldermans D., Bountioukos M., Onderwater E.E., Lee C.H., Serruys P.W. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol. 2003, 42(12):2063-2069.
70. Song H., Yoon C., Kattman S.J., Dengler J., Masse S., Thavaratnam T., Zandstra P.W. Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(8):3329-3334. (0905729106 [pii]). 10.1073/pnas.0905729106.
71. Stewart S., MacIntyre K., Hole D.J., Capewell S., McMurray J.J. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur. J. Heart Fail. 2001, 3(3):315-322.
72. Stoker M.E., Gerdes A.M., May J.F. Regional differences in capillary density and myocyte size in the normal human heart. Anat. Rec. 1982, 202(2):187-191. 10.1002/ar.1092020203.
73. Tohyama S., Hattori F., Sano M., Hishiki T., Nagahata Y., Matsuura T., Fukuda K. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 2013, 12(1):127-137. 10.1016/j.stem.2012.09.013.
74. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105(1):93-98.
75. van Berlo J.H., Kanisicak O., Maillet M., Vagnozzi R.J., Karch J., et al. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 2014, 509:337-341. 10.1038/nature13309.
76. van Laake L.W., Passier R., Monshouwer-Kloots J., Verkleij A.J., Lips D.J., Freund C., Mummery C.L. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 2007, 1(1):9-24. 10.1016/j.scr.2007.06.001.
77. Wehrens X.H., Kirchhoff S., Doevendans P.A. Mouse electrocardiography: an interval of thirty years. Cardiovasc. Res. 2000, 45(1):231-237.
78. Xu C., Police S., Hassanipour M., Li Y., Chen Y., Priest C., Gold J.D. Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells. Regen. Med. 2011, 6(1):53-66. 10.2217/rme.10.91.
79. Xue T., Cho H.C., Akar F.G., Tsang S.Y., Jones S.P., Marban E., Li R.A. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005, 111(1):11-20. 10.1161/01.CIR.0000151313.18547.A2.
80. Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E., Drazner M.H., American Heart Association Task Force on Practice, G 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2013, 62(16):e147-239. 10.1016/j.jacc.2013.05.019.
81. Yang X., Pabon L., Murry C.E. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 2014, 114(3):511-523. 10.1161/CIRCRESAHA.114.300558.
82. Zhu W.Z., Santana L.F., Laflamme M.A. Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes. PLoS ONE 2009, 4(4):e5407. 10.1371/journal.pone.0005407.